Navigation Links
SuperArray Bioscience Changes Name to SABiosciences and Moves Into New Larger Facility on Verge of Tenth Anniversary
Date:7/23/2008

FREDERICK, Md., July 23 /PRNewswire-USNewswire/ -- SuperArray Bioscience Corporation announced today it has changed its name to SABiosciences Corporation and moved to a brand new facility three times larger than the previous location. The changes reflect both its phenomenal growth over the last few years and its continuing expansion into other additional technologies besides gene expression analysis.

"We are not just a microarray company anymore," said Dave Martz, Vice President of Sales and Marketing at SABiosciences. "We are now and will continue to become so much more. SuperArray developed a solid reputation for delivering pathway-focused content for gene expression analysis, first with its hybridization-based microarrays and then most recently and much more successfully with real-time PCR Arrays. However, to provide our vision of a systems biology approach in a post-genomic era, SABiosciences now also offers gene function analysis solutions such as RNA interference, ELISA kits, cell-based reporter assays, as well as chromatin immunoprecipitation and other products for epigenomics research."

The move and name change occurs on the heels of receiving the Tech Council of Maryland Frederick County Firm of the Year Award in 2007 and just before their tenth anniversary as an incorporated company. Rapid growth and continually aggressive revenue projections allowed and indeed necessitated more personnel and capital equipment. After quickly outgrowing their currently available space of 18,000 square feet, the company moves to a new building with 43,000 square feet that supports 150 full-time employees. The company remains in Frederick, Maryland, only a few blocks away in the newly developed Westview South Office Research Center.

"To accommodate our rapid business growth and to better serve our customers, we built this new facility with state of the art R&D lab space, molecular and cell biology instruments, particle-free clean rooms," Martz continued. "As we approach our tenth anniversary this fall, we are very excited about the opportunities for our continued success that the new location will provide us. The name change better reflects our business model and vision for the future. We will continue bringing cutting edge technologies into every biological research laboratory with relevant biological content."

About SABiosciences Corporation

SABiosciences Corporation, a privately held biotechnology company founded in 1998, envisions a new and systematic approach to biological research in the post-genomic era. We have developed a broad portfolio of innovative and cost-effective research tools based on current knowledge and understanding of important biological pathways that merge the benefits of hypothesis-driven and discovery-based research. Our goal is to provide practical research tools that accelerate, simplify and improve life science research.


'/>"/>
SOURCE SABiosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Seahorse Bioscience Receives Poster Award from the European Association for the Study of Obesity
2. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
3. Monogram Biosciences Announces Second Quarter 2008 Financial Results Conference Call
4. PURE Bioscience Announces Distribution Agreement With Orchem Corporation
5. Pacific Biosciences Raises $100 Million to Fund Commercial Product Development
6. PURE Bioscience CEO to Ring NASDAQ Closing Bell
7. Ardea Biosciences Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout
8. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
9. Cell Biosciences Strengthens Management Team
10. Monogram Biosciences to Present at the Collins Stewart Fourth Annual Growth Conference
11. Abbott Invests Additional $20M in Isis Subsidiary Ibis Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... ... April 20, 2017 , ... Open Therapeutics and ... (IP) sharing and commercialization model. , The Center for Advancing Innovation helps institutions ... this effort is bringing the IP to the attention of the entrepreneurial community ...
(Date:4/19/2017)... (PRWEB) , ... April 18, 2017 , ... ... 1970s and has been a key device for generating monodisperse droplets of known ... droplet processes and for generating monodisperse solid particles by drying monodisperse droplets. ...
(Date:4/19/2017)... ... April 19, 2017 , ... Nobilis Therapeutics ... Company Seeks to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial ... an 81 patient clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in ...
(Date:4/19/2017)... 19, 2017 A new report published by Allied Market ... ," the global market was valued at $6,769 million in 2015, and is ... 2016 to 2022. ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) The cross-flow segment ...
Breaking Biology Technology:
(Date:4/19/2017)... April 19, 2017 The global ... landscape is marked by the presence of several large ... held by five major players - 3M Cogent, NEC ... accounted for nearly 61% of the global military biometric ... in the global military biometrics market boast global presence, ...
(Date:4/11/2017)... BEACH GARDENS, Fla. , April 11, 2017 ... identity management and secure authentication solutions, today announced ... contract by Intelligence Advanced Research Projects Activity (IARPA) ... for IARPA,s Thor program. "Innovation has ... onset and IARPA,s Thor program will allow us ...
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
Breaking Biology News(10 mins):